GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kimia Biosciences Ltd (BOM:530313) » Definitions » Sale Of Business

Kimia Biosciences (BOM:530313) Sale Of Business : ₹ Mil (TTM As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Kimia Biosciences Sale Of Business?

Kimia Biosciences's sale of business for the six months ended in . 20 was ₹0.00 Mil. It means Kimia Biosciences gained ₹0.00 Mil from selling business. Kimia Biosciences does not have enough years/quarters to calculate the sale of business for the trailing twelve months (TTM) ended in . 20.

Compared with last quarter (₹0.00 Mil in . 20 ), Kimia Biosciences gained the same money from selling business in . 20 (₹0.00 Mil).


Kimia Biosciences Sale Of Business Historical Data

The historical data trend for Kimia Biosciences's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kimia Biosciences Sale Of Business Chart

Kimia Biosciences Annual Data
Trend
Sale Of Business

Kimia Biosciences Semi-Annual Data
Sale Of Business

Kimia Biosciences Sale Of Business Calculation

The amount earned to sell business.



Kimia Biosciences Sale Of Business Related Terms

Thank you for viewing the detailed overview of Kimia Biosciences's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


Kimia Biosciences (BOM:530313) Business Description

Traded in Other Exchanges
N/A
Address
Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034
Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Deflazacort, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.

Kimia Biosciences (BOM:530313) Headlines

No Headlines